Authors: Shamira Cross (Nepean Cancer Care Centre, Nepean Hospital, Kingswood, Australia), Val Gebski (Crown Princess Mary Cancer Centre, Westmead Hospital, Wentworthville, Australia), Val Gebski (NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia), Drew Latty (Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, Australia), Kirsty Stuart (Crown Princess Mary Cancer Centre, Westmead Hospital, Wentworthville, Australia), Kirsty Stuart (Sydney Medical School, University of Sydney, Sydney, Australia), Kirsty Stuart (Westmead Breast Cancer Institute, Westmead Hospital, Wentworthville, Australia), Tim Wang (Crown Princess Mary Cancer Centre, Westmead Hospital, Wentworthville, Australia), Tim Wang (Sydney Medical School, University of Sydney, Sydney, Australia), Tim Wang (Westmead Breast Cancer Institute, Westmead Hospital, Wentworthville, Australia), Rachel Ward (Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, Australia), Rachel Ward (Crown Princess Mary Cancer Centre, Westmead Hospital, Wentworthville, Australia), Katrina West (Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, Australia), Katrina West (Crown Princess Mary Cancer Centre, Westmead Hospital, Wentworthville, Australia)
Show Affiliations
Hide Affiliations